Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis (Q34196943)

31 July 2017

3 references

17 September 2019

14 November 2020

21 January 2021

Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis (English)

1 reference

disease-modifying antirheumatic drug

31 July 2017

2 references

30 June 2019

21 January 2021

1 reference

17 September 2019

2 references

14 November 2020

1 reference

Alex R Kemper

1

1 reference

31 July 2017

Heather A Van Mater

2

1 reference

31 July 2017

Remy R Coeytaux

3

1 reference

31 July 2017

John W Williams

4

1 reference

31 July 2017

Gillian D Sanders

5

1 reference

31 July 2017

15 March 2012

7 references

31 July 2017

13 March 2019

17 June 2019

30 June 2019

17 September 2019

14 November 2020

21 January 2021

7 references

31 July 2017

13 March 2019

17 June 2019

30 June 2019

17 September 2019

14 November 2020

21 January 2021

12

1 reference

31 July 2017

29

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

6 references

13 March 2019

17 June 2019

30 June 2019

17 September 2019

14 November 2020

on focus list of Wikimedia project

21 January 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2431-12-29

0 references

cites work

Summary of worldwide pediatric malignancies reported after exposure to etanercept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Juvenile idiopathic arthritis: a review for the pediatrician

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

The German etanercept registry for treatment of juvenile idiopathic arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-29

The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-29

Leflunomide or methotrexate for juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-29

Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-29

Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-29

Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340294

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-29

Preliminary definition of improvement in juvenile arthritis

21 January 2018

1 reference

12 December 2020

Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

1 reference

12 December 2020

Evaluation of D-penicillamine in juvenile chronic arthritis. A double-blind, multicenter study

1 reference

12 December 2020

Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study

1 reference

12 December 2020

Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis

1 reference

12 December 2020

Measurement of health status in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Therapeutical and immunological effects of methylprednisolone pulse therapy in comparison with intravenous immunoglobulin. Treatment in patients with juvenile chronic arthritis

1 reference

12 December 2020

Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2431-12-29

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference